Sponsored Content REFERENCES AND FURTHER READING
1. Non-capillary microsampling of plasma in rat and mice in support of GLP studies. H. Stieltjes et al. Bioanalysis Journal Mar 20 2015.
2. Capillary microsampling (CMS) of 25 µL blood for the determination of toxicokinetic parameters in regulatory studies in animals. O. Jonsson et al. Bioanalysis 2012; 4 (6):661-674.
3. Capillary microsampling and analysis of 4-µl blood, plasma and serum samples to determine human α-synuclein elimination rate in mice. O. Jonsson, et al. Bioanalysis 2013; 5 (4):449-462.
4. ’Capillary microsampling’ O. Jonsson. Microsampling in Pharmaceutical Bioanalysis, 2013, Future Science Ltd. eISBN (PDF): 978-1-909453-58-6. pp 68–82.
5. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. K. Chapman et al. Drug Discovery Today 2013; 19 (5):528- 532.
6. Strategic Focus on 3R Principles Reveals Major Reductions in the Use of Animals in Pharmaceutical Toxicity Testing. E. Törnqvist et al. PLOS One July 23, 2014; DOI: 10.1371/journal.pone.0101638.
7. Miniaturized blood sampling techniques to benefit reduction in mice and refinement in nonhuman primates: applications to bioanalysis in toxicity studies with antibody-drug conjugates. A. Caron et al. J Am Assoc Lab Anim Sci. 2015;54(2):145-52.
8. One mouse, one pharmacokinetic profile: quantitative whole blood serial sampling for biotherapeutics. AP. Joyce et al. Pharm Res. 2014;31(7):1823-33.
9. ‘Capillary microsampling of liquid matrices. Better Science – Fewer animals’. Poster by O. Jonsson.
10. Video of tail vessel microsampling from mice on the UK’s NC3RS website.
EUR Tel: +46 (0)18 56 63 00 | US Tel: +1 908 755 0011 |
information@gyros.com |
www.gyros.com
Gyros, Gyrolab, Bioaffy, Rexxip, Gyrolab xP, Gyrolab xPlore and the Gyros logo are trademarks of the Gyros Group. All other trademarks are the property of their respective owners. Products and technologies from Gyros are covered by one or more patents and/or proprietary intellectual property rights. All infringements are prohibited and will be prosecuted. Please contact Gyros AB for further details. Products are for research use only. Not for use in diagnostic procedures. © Gyros AB 2015
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154